Louisiana Accuses Amgen Of Tying Cancer Drugs
The state of Louisiana and its health department have accused biotech company Amgen Inc. of using its monopoly in the market for one type of anti-cancer drug to boost the sales...To view the full article, register now.
Already a subscriber? Click here to view full article